Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.

Also called NCT04675762

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 118 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04675762
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04675762. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-15 (actual); primary completion 2025-12-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke
Condition
Stroke
Condition
Inflammation
Intervention (Drug)
Fingolimod
Intervention (Other)
Placebo
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
Shaoxing People's Hospital (class: other)
Collaborator
Affiliated Hospital of Jiaxing University (class: other)
Collaborator
Huizhou Municipal Central Hospital (class: other)
Collaborator
The Second Affiliated Hospital of Jiaxing University (class: other)
Collaborator
Jinhua Center Hospital (class: not stated)
Collaborator
Taizhou Hospital (class: other)

Record details

Record id
cardio:ct-nct04675762
Content hash
7b7a81f2474bfa6a497b19e9bf5802c198e77283378cd5389cefefc9d6cb92e6